INS and Anxiety: It refers to psychological barriers to initiation and persistence with insulin therapy.7 Factors described include: emotional states (needle anxiety, fear of hypoglycaemia, weight gain), cognitive (a lack of knowledge, distorted beliefs about insulin treatment), attitudes and behaviours of healthcare providers as well as the influences from the social and cultural environment.7